Literature DB >> 16237958

Immunomodulatory effects of curcumin.

V S Yadav1, K P Mishra, D P Singh, S Mehrotra, V K Singh.   

Abstract

Curcumin (diferuloylmethane), found in the spice turmeric, exhibits anti-inflammatory, antioxidant, and chemopreventive activities. However, the effect of curcumin on the immunological responses largely remains unknown. In this study we have investigated the effect of curcumin on mitogen (phytohaemagglutinin; PHA) stimulated T-cell proliferation, natural killer (NK) cell cytotoxicity, production of cytokines by human peripheral blood mononuclear cells (PBMCs), nitric oxide (NO) production in mouse macrophage cells, RAW-264.7. Furthermore, we have carried out an electromobility shift assay to elucidate the mechanism of action of curcumin at DNA protein interaction level. We observed that curcumin inhibits PHA-induced T-cell proliferation, interleukin-2 production, NO generation, and lipopolysachharide-induced nuclear factor-kappaB (NF-kappaB) and augments NK cell cytotoxicity. Our results suggest that curcumin most likely inhibits cell proliferation and cytokine production by inhibiting NF-kappaB target genes involved in the induction of these immune parameters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237958     DOI: 10.1080/08923970500242244

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  40 in total

1.  Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo.

Authors:  N M Rogers; S Kireta; P T H Coates
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

Review 2.  Carotenoids: biochemistry, pharmacology and treatment.

Authors:  Alireza Milani; Marzieh Basirnejad; Sepideh Shahbazi; Azam Bolhassani
Journal:  Br J Pharmacol       Date:  2016-10-29       Impact factor: 8.739

3.  Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation.

Authors:  Shazaan Hushmendy; Lalithapriya Jayakumar; Amy B Hahn; Devang Bhoiwala; Dipti L Bhoiwala; Dana R Crawford
Journal:  Nutr Res       Date:  2009-08       Impact factor: 3.315

4.  Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease.

Authors:  C B Larmonier; M T Midura-Kiela; R Ramalingam; D Laubitz; N Janikashvili; N Larmonier; F K Ghishan; P R Kiela
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

Review 5.  "Spicing up" of the immune system by curcumin.

Authors:  Ganesh Chandra Jagetia; Bharat B Aggarwal
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

6.  Bio-evaluation of the role of chitosan and curcumin nanoparticles in ameliorating genotoxicity and inflammatory responses in rats' gastric tissue followed hydroxyapatite nanoparticles' oral uptake.

Authors:  Israa F Mosa; Haitham H Abd; Abdelsalam Abuzreda; Nadhom Assaf; Amenh B Yousif
Journal:  Toxicol Res (Camb)       Date:  2020-08-03       Impact factor: 3.524

7.  The Clinical Use of Curcumin for the Treatment of Rheumatoid Arthritis: A Systematic Review of Clinical Trials.

Authors:  Mohammad Bagherniya; Mina Darand; Gholamreza Askari; Paul C Guest; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent.

Authors:  Claire Billerey-Larmonier; Jennifer K Uno; Nicolas Larmonier; Anna J Midura; Barbara Timmermann; Fayez K Ghishan; Pawel R Kiela
Journal:  Inflamm Bowel Dis       Date:  2008-06       Impact factor: 5.325

9.  Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up.

Authors:  Pia Allegri; Antonio Mastromarino; Piergiorgio Neri
Journal:  Clin Ophthalmol       Date:  2010-10-21

10.  Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor.

Authors:  Xin Zhao; Chuang Wang; Jun-Fang Zhang; Li Liu; Ai-Ming Liu; Qing Ma; Wen-Hua Zhou; Ying Xu
Journal:  Psychopharmacology (Berl)       Date:  2013-12-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.